Pendulum GLP-1 Probiotic is formulated by a team of PhD scientists from Johns Hopkins, Harvard, Berkeley and Stanford backed by Mayo Clinic, Sequoia Capital and over $111 million in research investment combining Akkermansia muciniphila with complementary probiotic strains specifically selected to support gut barrier integrity, microbiome diversity and the gut signalling environment associated with appetite and craving management
As use continues to grow, emergency physicians will encounter these medications more frequently across a broader patient population
More than 100 published studies have evaluated the compound in in-vitro and animal model systems, including gastrointestinal cytoprotection models, tendon and ligament tissue research, and neurological signaling pathway investigations
How it compares: TRT, GLP-1 medications, and other peptides Three questions come up constantly, so here are direct answers
Both are incretin hormones your gut releases after eating, but they differ in function